Net Income (Loss) per Share - Summary Of Potentially Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share (Details) - shares |
3 Months Ended | |
|---|---|---|
Apr. 02, 2023 |
Apr. 03, 2022 |
|
| Stock options outstanding | ||
| Subsidiary Sale Of Stock [Line Items] | ||
| Anti-dilutive securities (in shares) | 4,608,824 | 5,536,905 |
| Restricted stock units and performance restricted stock units outstanding | ||
| Subsidiary Sale Of Stock [Line Items] | ||
| Anti-dilutive securities (in shares) | 9,821,622 | 917,079 |
| Private Placement Warrants outstanding | ||
| Subsidiary Sale Of Stock [Line Items] | ||
| Anti-dilutive securities (in shares) | 6,000,000 | 0 |
| Employee stock purchase plan estimated shares | ||
| Subsidiary Sale Of Stock [Line Items] | ||
| Anti-dilutive securities (in shares) | 349,988 | 78,198 |
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|